Bill funds research into a serious health problem affecting millions of women.
H.R. 8160 — Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 · Filed by Yassamin Ansari (D-AZ) · 29 cosponsors · Introduced Mar 30, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
The bill tells the National Institutes of Health to study PMDD. It also tells the Department of Health and Human Services to study it. PMDD hits 5 to 8 percent of women and people assigned female at birth. It is a severe problem. The bill pays for public notice campaigns. It pays for training for doctors and nurses. It pays for facts about PMDD. The goal is to help more people get found and treated.
Who it affects
Women and people assigned female at birth with PMDD will get better help. Doctors and nurses will learn how to spot and treat PMDD. Schools and hospitals that train health workers will get money.
One thing to notice
The bill requires research to include people from many races, groups, and income levels. This may show if some groups have a harder time getting found or treated.
From the analysis of the bill text, linked under Primary records below.
Where it stands
29 cosponsors: 29 Democrats.
- Mar 30, 2026 — Introduced · Congress.gov: “Introduced in House”
- Mar 30, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 groups reported lobbying about this bill. They filed 1 reports from Jun 2026 to Jun 2026.
Those reports show $96,000 in lobbying spending. Each report lists about 31 bills. So that money was not all for this bill.
More groups named this bill than 0% of bills with any report.
Yassamin Ansari, who sponsored the bill, received $229,033 from PACs for the 2026 election.
- American College of Obstetricians and Gynecologists — $96,000 in 1 report
Lobbying is legal. These reports show who lobbied about this bill, not what changed.
Words to know
- National Institutes of Health — A government agency that pays for and runs medical research.
- Department of Health and Human Services — A government agency that runs health programs and public health.
- public notice campaigns — Public work to teach people about a health problem.
- lobbying — Trying to influence lawmakers about a bill. Companies and groups pay people to do this.
- PACs — Groups that collect money and give it to candidates for office.
- sponsored — To sponsor a bill is to introduce it in Congress and put your name on it.
How this was measured
Analysis — Quorum's AI read the full bill text on Apr 14, 2026; transparency and hidden-provision scores are compared against the median of 14,206 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-09-17.
“Bill funds research into a serious health problem affecting millions of women.” QuorumCivic. https://share.quorumcivic.app/bill/119/hr8160/simple Report an error